|Bid||78.76 x 800|
|Ask||79.17 x 1000|
|Day's Range||78.22 - 80.60|
|52 Week Range||73.12 - 88.32|
|Beta (5Y Monthly)||0.61|
|PE Ratio (TTM)||33.35|
|Earnings Date||Feb 02, 2022 - Feb 07, 2022|
|Forward Dividend & Yield||1.12 (1.43%)|
|Ex-Dividend Date||Dec 02, 2021|
|1y Target Est||93.79|
Subscribe to Yahoo Finance Plus to view Fair Value for BAXLearn more
The Zacks Analyst Blog Highlights: Abbott Laboratories, West Pharmaceuticals Services, Baxter International and Chemed Corp
Hillrom (NYSE: HRC) today announced that its shareholders have voted to approve the previously announced pending acquisition by Baxter International Inc. (NYCE: BAX) at a special meeting. Hillrom shareholders voted overwhelmingly in favor of the transaction. Under the terms of the merger agreement, Hillrom shareholders will receive $156.00 per share in cash for every share of Hillrom stock they own immediately prior to the effective time of the merger.
Abbott Laboratories (ABT), West Pharmaceuticals Services (WST), Baxter International (BAX) and Chemed Corporation (CHE) are high-yield dividend stocks with sustainable business models.